Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis. I. The immune pathogenetic hypothesis.

L Bergamini1, L Durelli

  • 1Istituto di Clinica delle Malattie del Sistema Nervoso, Università Torino.

Rivista Di Neurologia
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological Society.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2011
Same author

Observations on the pathogenesis of malignant diphtheria.

Policlinico infantile·2010
Same author

Insulin-like growth factor-1 (IGF-1): relation with cognitive functioning and neuroimaging marker of brain damage in a sample of hypertensive elderly subjects.

Archives of gerontology and geriatrics·2009
Same author

Relations between a novel, reliable, and rapid index of arterial compliance (PP-HDI) and well-established inidices of arterial blood pressure (ABP) in a sample of hypertensive elderly subjects.

Archives of gerontology and geriatrics·2009
Same author

A scale evaluating the emotivity and well-being of elderly (Italian acronym: SVEBA): analysis of psychometric characteristics.

Archives of gerontology and geriatrics·2009
Same author

Neutralizing antibodies in multiple sclerosis patients treated with 375 micrograms interferon-beta-1b.

Expert opinion on biological therapy·2009
Same journal

[Dexamethasone therapy in Huntington chorea: preliminary results].

Rivista di neurologia·1991
Same journal

[Cerebrovascular manifestations while taking combined estrogens and progestins for contraceptive purposes. Clinical cases].

Rivista di neurologia·1991
Same journal

Benign focal amyotrophy: a longitudinal study (13-15 years) in 3 cases.

Rivista di neurologia·1991
Same journal

[Maps of somatosensory evoked potentials from the arm in patients with neoplasms and post-traumatic brain lesions].

Rivista di neurologia·1991
Same journal

[Diurnal worsening in Parkinson patients treated with levodopa].

Rivista di neurologia·1991
Same journal

[Status epilepticus in chronically dialyzed patients treated with erythropoietin].

Rivista di neurologia·1991
See all related articles

Multiple Sclerosis (MS) may involve a transmissible agent, possibly a virus, interacting with genetic factors. This agent could trigger immune responses that attack the central nervous system (CNS), leading to demyelination.

Area of Science:

  • Neuroimmunology
  • Central Nervous System (CNS) Diseases
  • Demyelinating Diseases

Background:

  • Chronic relapsing demyelinating diseases of the CNS, like Multiple Sclerosis (MS), are suggested by animal models to be induced by viruses or myelin antigen sensitization.
  • Epidemiological data implies an environmental transmissible agent acting on a genetic susceptibility may contribute to MS pathogenesis.
  • A hypothesis suggests this agent could be antigenically related to human T-lymphotropic viruses (HTLV).

Purpose of the Study:

  • To explore the potential role of a transmissible agent in the pathogenesis of chronic relapsing demyelinating diseases of the CNS.
  • To investigate the mechanisms by which a potential viral agent or immune system alteration contributes to demyelination in MS.
  • To understand the immune cell interactions within the CNS during MS, including T lymphocyte traffic and macrophage activation.

Related Experiment Videos

Main Methods:

  • Review of animal models for chronic demyelinating CNS diseases.
  • Analysis of epidemiological data, including studies on emigrants and MS epidemics.
  • Examination of immunological mechanisms involving T lymphocytes, antigen presentation, and macrophage activity in the CNS.

Main Results:

  • Animal models demonstrate viral or myelin antigen-induced demyelination.
  • Epidemiological studies suggest a transmissible agent and genetic factors in MS.
  • Evidence indicates activated T lymphocyte traffic across the blood-brain barrier in MS patients.
  • Antigen-presenting cells (astrocytes, endothelial cells) and activated macrophages contribute to myelin phagocytosis in the CNS.
  • Non-specific immune cells proliferate in the CNS, producing antibodies not directly linked to MS pathogenesis.

Conclusions:

  • A transmissible agent, potentially viral and related to HTLV, may initiate or exacerbate MS by altering the immune system or myelin antigens.
  • Immune cells, including sensitized T lymphocytes and activated macrophages, play a critical role in CNS demyelination in MS.
  • The presence of specific antigen-presenting cells and abnormal immune cell proliferation within the CNS contributes to the ongoing autoimmune process in MS.